667 results on '"Mahr C"'
Search Results
2. Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report
3. Initial Safety Cohort Analysis: Prospective Multi-Center Randomized Study for Evaluating The EVAHEART®2 Left Ventricular Assist System (The COMPETENCE Trial)
4. (93) Race and Incidence of Right Heart Failure after Left Ventricular Assist Device Implantation
5. Topical instillation of vancomycin lowers the rate of CSF shunt infections in children
6. sandTES – An Active Thermal Energy Storage System based on the Fluidization of Powders
7. Impella 5.5 Support Prior to Heart and Kidney Transplantation
8. The COMPETENCE Trial: Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System
9. Single Acute Mechanical Circulatory Support Device Use is Associated with Reduced Mortality Compared to Multi-Agent Drug Therapy Alone for Cardiogenic Shock: An Analysis of the Cardiogenic Shock Working Group Registry
10. (476) - Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report
11. (475) - Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report
12. (245) - Practice Variation in Temporary MCS Device Choice in Cardiogenic Shock
13. Compatibility of Novel Cardiogenic Shock Phenotypes from the Cardiogenic Shock Working Group (CSWG) with the SCAI Staging System
14. Estimation of Stressed Blood Volume in Patients with Cardiogenic Shock from Acute Myocardial Infarction and Decompensated Heart Failure
15. Clinical Outcomes Associated with Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock
16. Outcomes after Heart Transplantation and Total Artificial Heart Implantation: A Multicenter Study
17. Impact of Age on Outcomes in Patients with Cardiogenic Shock
18. Impact of Gastrointestinal Bleeding Following LVAD Implant in a Destination Therapy Population
19. Identifying Right Ventricular Dysfunction Increases the Predictive Value of SCAI Staging: A Case for an ‘R’ Modifier
20. An Analysis of Driveline Infections with Left Ventricular Assist Devices Utilizing Carbothane versus Pellethane Driveline Sheaths
21. A Bridged Approach to Heart Transplantation Using ECMO and Total Artificial Heart Implantation
22. (177) Initial Safety Cohort Analysis: Prospective Multi-Center Randomized Study for Evaluating The EVAHEART®2 Left Ventricular Assist System (The COMPETENCE Trial)
23. Derivation and Validation of Three Novel Phenotypes of Cardiogenic Shock
24. Variability in Blood Pressure Assessment in Patients Supported with HeartMate 3
25. Antithrombotics after Intracranial Hemorrhage in Patients with Left Ventricular Assist Devices
26. TAH Portable Driver: It's Alarming, but is It Broken?
27. Cost-Effectiveness of a Small Intrapericardial Centrifugal LVAD versus Medical Management in Destination Therapy Patients in the UK
28. Clinical and Hemometabolic Status Impact Transitions in Acute on Chronic Heart Failure Shock: Insights from the CSWG Registry
29. Pulmonary Artery Catheter Usage and Mortality in Cardiogenic Shock
30. Acute Anticoagulation after Ischemic Stroke in Patients with Left Ventricular Assist Devices
31. Long-Term Neurocognitive Outcomes in LVAD Recipients
32. Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Small Intrapericardial Centrifugal LVAD
33. New Approach to the Treatment of Patients in Intermac 1 or 2 Biventricular Failure and on ECMO with the Syncardia Temporary Total Artificial Heart
34. Cost-Effectiveness of a Small Intrapericardial Centrifugal LVAD versus Medical Management and Heart Transplantation
35. Impact of Stroke Onset Severity on 2-Year Survival in Destination Therapy Patients Supported by Centrifugal Flow versus Axial Flow Ventricular Assist Devices
36. The Effect of Right Ventricular Arterial Uncoupling on Mortality in Cardiogenic Shock
37. Impact of the Thoracotomy Implant Approach on Patient Self-Reported Quality of Life in the HVAD LATERAL Trial
38. Blood Pressure Management Ameliorates the Severity of Neurological Events
39. Does Increasing Experience in Implementing the Blood Pressure Management Protocol in the ENDURANCE Supplemental Trial Result in Better Outcomes?
40. Change in Heart Rate from Pre-Implant to Discharge in Destination Therapy is Associated with Mortality and Admissions in LVAD Patients- A Substudy of the ENDURANCE trial
41. Ex-Vivo Perfusion of a Human Heart Recovered from a DCD Donor for 13 Hours on Organ Care System Platform
42. Where Do Patients with VADs Prefer to Spens Their Last Days?
43. Effect of Transplant Rates on Benefit of Left Ventricular Assist Device versus Inotrope Support
44. The Treatment of Patients with Advanced Heart Failure Ineligible for Cardiac Transplantation with the HeartWare Ventricular Assist Device: Results of the ENDURANCE Supplement Trial
45. Steam reforming of methanol over oxide decorated nanoporous gold catalysts: a combined in situ FTIR and flow reactor study
46. Wie plausibel ist der normative Krankheitsbegriff von Clouser, Culver und Gert?
47. Reduction in Post-Heart Transplant ICU and Total Length of Stay by Standardization of Care Via a Multidisciplinary Approach
48. Early Results of Biventricular Support with Durable, Intracorporeal Continuous Flow Centrifugal Ventricular Assist Devices: Analysis from INTERMACS
49. Utility of Heart Transplant by Waitlist Mortality and Donor/Recipient Match
50. Comparison of Device-Related Infections between Two Continuous Flow Ventricular Assist Devices
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.